Rare Variants in Known Susceptibility Loci and Their Contribution to Risk of Lung Cancer

被引：24

作者：

Liu, Yanhong ^{[1
]}

Lusk, Christine M. ^{[2
]}

Cho, Michael H. ^{[3
,4
]}

Silverman, Edwin K. ^{[3
,4
]}

Qiao, Dandi ^{[3
,4
]}

Zhang, Ruyang ^{[5
]}

Scheurer, Michael E. ^{[6
]}

Kheradmand, Farrah ^{[1
,7
]}

Wheeler, David A. ^{[8
]}

Tsavachidis, Spiridon ^{[1
]}

Armstrong, Georgina ^{[1
]}

Zhu, Dakai ^{[1
,9
]}

Wistuba, Ignacio I. ^{[10
]}

Chow, Chi-Wan B. ^{[10
]}

Behrens, Carmen ^{[11
]}

Pikielny, Claudio W. ^{[12
]}

Neslund-Dudas, Christine ^{[13
]}

Pinney, Susan M. ^{[14
]}

Anderson, Marshall ^{[14
]}

Kupert, Elena ^{[14
]}

Bailey-Wilson, Joan ^{[15
]}

Gaba, Colette ^{[16
]}

Mandal, Diptasri ^{[17
]}

You, Ming ^{[18
]}

de Andrade, Mariza ^{[19
]}

Yang, Ping ^{[19
]}

Field, John K. ^{[20
]}

Liloglou, Triantafillos ^{[20
]}

Davies, Michael ^{[20
]}

Lissowska, Jolanta ^{[21
]}

Swiatkowska, Beata ^{[22
]}

Zaridze, David ^{[23
]}

Mukeriya, Anush ^{[23
]}

Janout, Vladimir ^{[24
]}

Holcatova, Ivana ^{[25
]}

Mates, Dana ^{[26
]}

Milosavljevic, Sasa ^{[27
]}

Scelo, Ghislaine ^{[28
]}

Brennan, Paul ^{[28
]}

McKay, James ^{[28
]}

Liu, Geoffrey ^{[29
]}

Hung, Rayjean J. ^{[30
]}

Christiani, David C. ^{[5
]}

Schwartz, Ann G. ^{[2
]}

Amos, Christopher I. ^{[1
,9
]}

Spitz, Margaret R. ^{[1
]}

机构：

[1] Baylor Coll Med, Dept Med, Dan L Duncan Comprehens Canc Ctr, Houston, TX 77030 USA

[2] Wayne State Univ, Karmanos Canc Inst, Detroit, MI USA

[3] Brigham & Womens Hosp, Dept Med, Channing Div Network Med, 75 Francis St, Boston, MA 02115 USA

[4] Harvard Med Sch, Boston, MA USA

[5] Harvard Univ, Sch Publ Hlth, 665 Huntington Ave, Boston, MA 02115 USA

[6] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[7] Michael E DeBakey VA Med Ctr, Houston, TX USA

[8] Baylor Coll Med, Dept Mol & Human Genet, Human Genome Sequence Ctr, Houston, TX 77030 USA

[9] Baylor Coll Med, Inst Clin & Translat Res, Houston, TX 77030 USA

[10] Univ Texas MD Anderson Canc Ctr, Dept Translat Mol Pathol, Houston, TX 77030 USA

[11] Univ Texas MD Anderson Canc Ctr, Dept Thorac Head & Neck Med Oncol, Houston, TX 77030 USA

[12] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, 1 Med Ctr Dr, Lebanon, NH 03756 USA

[13] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA

[14] Univ Cincinnati, Coll Med, Cincinnati, OH USA

[15] Natl Human Genome Res Inst, Bethesda, MD USA

[16] Univ Toledo, Coll Med, 2801 W Bancroft St, Toledo, OH 43606 USA

[17] Louisiana State Univ, Hlth Sci Ctr, New Orleans, LA USA

[18] Med Coll Wisconsin, Milwaukee, WI 53226 USA

[19] Mayo Clin, Coll Med, Rochester, MN USA

[20] Univ Liverpool, Dept Mol & Clin Canc Med, Roy Castle Lung Canc Res Programme, Liverpool, Merseyside, England

[21] Maria Sklodowska Curie Inst Oncol Ctr, Warsaw, Poland

[22] Nofer Inst Occupat Med, Dept Environm Epidemiol, Lodz, Poland

[23] Russian NN Blokhin Canc Res Ctr, Moscow, Russia

[24] Palacky Univ, Fac Hlth Sci, Olomouc, Czech Republic

[25] Charles Univ Prague, Fac Med 2, Inst Publ Hlth & Prevent Med, Prague, Czech Republic

[26] Natl Inst Publ Hlth, Bucharest, Romania

[27] Int Org Canc Prevent & Res, Belgrade, Serbia

[28] Int Agcy Res Canc, Lyon, France

[29] Princess Margaret Canc Ctr, Toronto, ON, Canada

[30] Sinai Hlth Syst, Lunenfeld Tanenbaum Res Inst, Toronto, ON, Canada

来源：

JOURNAL OF THORACIC ONCOLOGY | 2018年 / 13卷 / 10期

基金：

美国国家卫生研究院;

关键词：

Exome sequencing; Rare variants; Lung cancer; Susceptibility loci; GENOME-WIDE ASSOCIATION; BRCA2; MUTATION; REVEALS; IMPACT;

D O I：

10.1016/j.jtho.2018.06.016

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Background: Genome-wide association studies are widely used to map genomic regions contributing to lung cancer (LC) susceptibility, but they typically do not identify the precise disease-causing genes/variants. To unveil the inherited genetic variants that cause LC, we performed focused exome-sequencing analyses on genes located in 121 genome-wide association study-identified loci previously implicated in the risk of LC, chronic obstructive pulmonary disease, pulmonary function level, and smoking behavior. Methods: Germline DNA from 260 case patients with LC and 318 controls were sequenced by utilizing VCRome 2.1 exome capture. Filtering was based on enrichment of rare and potential deleterious variants in cases (risk alleles) or controls (protective alleles). Allelic association analyses of single-variant and gene-based burden tests of multiple variants were performed. Promising candidates were tested in two independent validation studies with a total of 1773 case patients and 1123 controls. Results: We identified 48 rare variants with deleterious effects in the discovery analysis and validated 12 of the 43 candidates that were covered in the validation platforms. The top validated candidates included one well-established truncating variant, namely, BRCA2, DNA repair associated gene (BRCA2) K3326X (OR = 2.36, 95% confidence interval [CI]: 1.38-3.99), and three newly identified variations, namely, lymphotoxin beta gene (LTB) p.Leu87Phe (OR = 7.52, 95% CI: 1.01-16.56), prolyl 3-hydroxylase 2 gene (P3H2) p.Gln185His (OR = 5.39, 95% CI: 0.75-15.43), and dishevelled associated activator of morphogenesis 2 gene (DAAM2) p.Asp762Gly (OR = 0.25, 95% CI: 0.10-0.79). Burden tests revealed strong associations between zinc finger protein 93 gene (ZNF93), DAAM2, bromodomain containing 9 gene (BRD9), and the gene LTB and LC susceptibility. Conclusion: Our results extend the catalogue of regions associated with LC and highlight the importance of germline rare coding variants in LC susceptibility. (C) 2018 International Association for the Study of Lung Cancer. Published by Elsevier Inc. All rights reserved.

引用

页码：1483 / 1495

页数：13

共 50 条

[1] Establishing the role of rare coding variants in known Parkinson's disease risk loci
Jansen, Iris E.
Gibbs, J. Raphael
Nalls, Mike A.
Price, T. Ryan
Lubbe, Steven
van Rooij, Jeroen
Uitterlinden, Andre G.
Kraaij, Robert
Williams, Nigel M.
Brice, Alexis
Hardy, John
Wood, Nicholas W.
Morris, Huw R.
Gasser, Thomas
Singleton, Andrew B.
Heutink, Peter
Sharma, Manu
NEUROBIOLOGY OF AGING, 2017, 59 : 220.e11 - 220.e18
[2] Copy Number Variants Are Ovarian Cancer Risk Alleles at Known and Novel Risk Loci
DeVries, Amber A.
Dennis, Joe
Tyrer, Jonathan P.
Peng, Pei-Chen
Coetzee, Simon G.
Reyes, Alberto L.
Plummer, Jasmine T.
Davis, Brian D.
Chen, Stephanie S.
Dezem, Felipe Segato
Aben, Katja K. H.
Anton-Culver, Hoda
Antonenkova, Natalia N.
Beckmann, Matthias W.
Beeghly-Fadiel, Alicia
Berchuck, Andrew
Bogdanova, Natalia, V
Bogdanova-Markov, Nadja
Brenton, James D.
Butzow, Ralf
Campbell, Ian
Chang-Claude, Jenny
Chenevix-Trench, Georgia
Cook, Linda S.
DeFazio, Anna
Doherty, Jennifer A.
Dork, Thilo
Eccles, Diana M.
Eliassen, A. Heather
Fasching, Peter A.
Fortner, Renee T.
Giles, Graham G.
Goode, Ellen L.
Goodman, Marc T.
Gronwald, Jacek
Hakansson, Niclas
Hildebrandt, Michelle A. T.
Huff, Chad
Huntsman, David G.
Jensen, Allan
Kar, Siddhartha
Karlan, Beth Y.
Khusnutdinova, Elza K.
Kiemeney, Lambertus A.
Kjaer, Susanne K.
Kupryjanczyk, Jolanta
Labrie, Marilyne
Lambrechts, Diether
Le, Nhu D.
Lubinski, Jan
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2022, 114 (11): : 1533 - 1544
[3] Rare germline deleterious variants increase susceptibility for lung cancer
Sang, Jian
Zhang, Tongwu
Kim, Jung
Li, Mengying
Pesatori, Angela C.
Consonni, Dario
Song, Lei
Liu, Jia
Zhao, Wei
Hoang, Phuc H.
Campbell, Dave S.
Feng, James
D'Arcy, Monica E.
Synnott, Naoise
Chen, Yingxi
Wu, Zeni
Zhu, Bin
Yang, Xiaohong R.
Brown, Kevin M.
Choi, Jiyeon
Shi, Jianxin
Landi, Maria Teresa
HUMAN MOLECULAR GENETICS, 2022, 31 (20) : 3558 - 3565
[4] Characterizing Genetic Risk at Known Prostate Cancer Susceptibility Loci in African Americans
Haiman, Christopher A.
Chen, Gary K.
Blot, William J.
Strom, Sara S.
Berndt, Sonja I.
Kittles, Rick A.
Rybicki, Benjamin A.
Isaacs, William B.
Ingles, Sue A.
Stanford, Janet L.
Diver, W. Ryan
Witte, John S.
Chanock, Stephen J.
Kolb, Suzanne
Signorello, Lisa B.
Yamamura, Yuko
Neslund-Dudas, Christine
Thun, Michael J.
Murphy, Adam
Casey, Graham
Sheng, Xin
Wan, Peggy
Pooler, Loreall C.
Monroe, Kristine R.
Waters, Kevin M.
Le Marchand, Loic
Kolonel, Laurence N.
Stram, Daniel O.
Henderson, Brian E.
PLOS GENETICS, 2011, 7 (05):
[5] Contribution of Rare Variants to Bipolar Disorder Susceptibility
Forstner, Andreas J.
Karhoff, Katharina
Maaser-Hecker, Anna
Streit, Fabian
Sivalingam, Sugirthan
Ludwig, Kerstin U.
Degenhardt, Franziska
Herms, Stefan
Hoffmann, Per
Witt, Stephanie H.
Maier, Wolfgang
Schulze, Thomas G.
Albus, Margot
Borrmann-Hassenbach, Margitta
Bauer, Michael
Reif, Andreas
Moebus, Susanne
Dannlowski, Udo
Kircher, Tilo
Cichon, Sven
Rietschel, Marcella
Noethen, Markus M.
BIOLOGICAL PSYCHIATRY, 2021, 89 (09) : S63 - S64
[6] Rare deleterious germline variants and risk of lung cancer
Yanhong Liu
Jun Xia
James McKay
Spiridon Tsavachidis
Xiangjun Xiao
Margaret R. Spitz
Chao Cheng
Jinyoung Byun
Wei Hong
Yafang Li
Dakai Zhu
Zhuoyi Song
Susan M. Rosenberg
Michael E. Scheurer
Farrah Kheradmand
Claudio W. Pikielny
Christine M. Lusk
Ann G. Schwartz
Ignacio I. Wistuba
Michael H. Cho
Edwin K. Silverman
Joan Bailey-Wilson
Susan M. Pinney
Marshall Anderson
Elena Kupert
Colette Gaba
Diptasri Mandal
Ming You
Mariza de Andrade
Ping Yang
Triantafillos Liloglou
Michael P. A. Davies
Jolanta Lissowska
Beata Swiatkowska
David Zaridze
Anush Mukeria
Vladimir Janout
Ivana Holcatova
Dana Mates
Jelena Stojsic
Ghislaine Scelo
Paul Brennan
Geoffrey Liu
John K. Field
Rayjean J. Hung
David C. Christiani
Christopher I. Amos
npj Precision Oncology, 5
[7] Pathogenic Germline Rare Variants and Risk of Lung Cancer
Liu, Y.
Mckay, J.
Xiao, X.
Field, J.
Davies, M.
Brennan, P.
Liu, G.
Hung, R. J.
Christiani, D. C.
Amos, C.
JOURNAL OF THORACIC ONCOLOGY, 2019, 14 (10) : S689 - S690
[8] Using rare variants to characterize lung cancer risk
Craig, Daniel J.
Elsamaloty, Mazzin
Blomquist, Thomas M.
Crawford, Erin L.
Willey, James C.
CANCER RESEARCH, 2018, 78 (13)
[9] Rare deleterious germline variants and risk of lung cancer
Liu, Yanhong
Xia, Jun
McKay, James
Tsavachidis, Spiridon
Xiao, Xiangjun
Spitz, Margaret R.
Cheng, Chao
Byun, Jinyoung
Hong, Wei
Li, Yafang
Zhu, Dakai
Song, Zhuoyi
Rosenberg, Susan M.
Scheurer, Michael E.
Kheradmand, Farrah
Pikielny, Claudio W.
Lusk, Christine M.
Schwartz, Ann G.
Wistuba, Ignacio I.
Cho, Michael H.
Silverman, Edwin K.
Bailey-Wilson, Joan
Pinney, Susan M.
Anderson, Marshall
Kupert, Elena
Gaba, Colette
Mandal, Diptasri
You, Ming
de Andrade, Mariza
Yang, Ping
Liloglou, Triantafillos
Davies, Michael P. A.
Lissowska, Jolanta
Swiatkowska, Beata
Zaridze, David
Mukeria, Anush
Janout, Vladimir
Holcatova, Ivana
Mates, Dana
Stojsic, Jelena
Scelo, Ghislaine
Brennan, Paul
Liu, Geoffrey
Field, John K.
Hung, Rayjean J.
Christiani, David C.
Amos, Christopher I.
NPJ PRECISION ONCOLOGY, 2021, 5 (01)
[10] Rare Coding Variants and Breast Cancer Risk: Evaluation of Susceptibility Loci Identified in Genome-Wide Association Studies
Zhang, Yanfeng
Long, Jirong
Lu, Wei
Shu, Xiao-Ou
Cai, Qiuyin
Zheng, Ying
Li, Chun
Li, Bingshan
Gao, Yu-Tang
Zheng, Wei
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2014, 23 (04) : 622 - 628

← 1 2 3 4 5 →